Schedule 13G ownership disclosure

Alexza Pharmaceuticals Inc.

Security class unavailable · CUSIP: 015384209

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
860,845
Percent of class
4.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895421-15-000030
Form type
SC 13G
Filer
Alexza Pharmaceuticals Inc.
CIK
CIK 1344413
Filed
Feb 05, 2015
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub